Exercise TrainingNCT05396963
Egg White Supplementation in High-Intensity Functional Training
A study testing Egg white, Whey protein and Maltodextrin in people with Exercise Training and Dietary Supplements, run by Aristotle University Of Thessaloniki at 1 site in Greece.
Trial summary
High-intensity functional training (HIFT), a new version of high-intensity interval training, has gained interest in recent years. HIFT is based on the CrossFit training template and includes multijoint movement patterns via both endurance and strengthening exercises. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Exercise Training, Dietary Supplements
- What is being tested?
- Egg white, Whey protein and Maltodextrin
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteGreece
- Study dates
- 1 Nov 2021to 30 Sep 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Regular training (mixed endurance and resistance training 3 to 6 times a week, 50 min each session, for the past 4 months), as assessed by gym records or questionnaires
- Clearance from a pathologist or cardiologist to perform maximal exercise
- Mixed isoenergetic diet for the past 4 months
Who cannot join
- Smoking (even one cigarette or nicotine-containing device over the past 6 months)
- Any injuries to the musculoskeletal system that could interfere with the execution of training
- Chronic disease
- Egg allergy
- Milk allergy
- Pregnancy, lactation, or planning a pregnancy within the duration of the study
Show all 9Show fewer
- Regular use of prescription medicine or supplements that might affect muscle function or recovery over the past month
- Intermittent or religious fasting
- Any vegetarian, ketogenic or protein diet
Trial locations and contacts
1 site in 1 country.
Greece1 site
Laboratory of Evaluation of Human Biological Performance
Thessaloniki, 57001
About this study
Official title: Effects of Egg White Supplementation on Body Composition, Physical Performance, and Amino Acid Profile of Individuals Undergoing High-intensity Functional Training
High-intensity functional training (HIFT), a new version of high-intensity interval training, has gained interest in recent years. HIFT is based on the CrossFit training template and includes multijoint movement patterns via both endurance and strengthening exercises. Research has shown positive effects of HIFT on body composition, cardiorespiratory fitness, and muscle performance of young individuals. The effectiveness of HIFT in higher ages and its protein requirements are less well documented. Protein requirements have been widely investigated in resistance training, where it has been found that protein supplementation may have additive beneficial effects on muscle strength and lean body mass. However, there is a research gap regarding the adaptations to HIFT when combined with protein supplementation.
Thus, the aim of this research is to compare the effects of egg white supplementation, whey protein supplementation (as a positive comparator), and maltodextrin (a carbohydrate as placebo) on body composition, physical performance, and plasma amino acid profile in young and middle-aged trained individuals of both sexes who perform HIFT. Participants will take all three supplements for 6 weeks each, with 2 weeks of washout (no supplementation) in between, in random and counterbalanced order. Researchers will not know the supplementation status of the participants. Participants will receive 0.6 g of protein or placebo per kg body weight daily on top of isoenergetic dietary plans to avoid differences in energy intake that might compromise the validity of the study. The dietary plans will be individualized and will provided 1.0 g protein/kg body weight/day. The HIFT protocol will include multimodal patterns of movement, combining endurance and strengthening exercises with the use of equipment such as Total Resistance eXercise (TRX), Bosu, kettlebells, and barbells.
Participants will undergo measurements of muscle strength, muscle endurance, aerobic capacity, and body composition at the beginning and end of the study, as well as during the two washout periods. Also, plasma amino acids, hematology, biochemistry, and hormones will be measured. Comparison of all these outcome measures between supplements will reveal whether protein supplementation is useful in HIFT.
- Conditions
- Exercise Training, Dietary Supplements
- Being tested
- Egg white, Whey protein, Maltodextrin
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Egg whiteDietary supplement
Intake of egg white
Whey proteinDietary supplement
Intake of whey protein
MaltodextrinDietary supplement
Intake of maltodextrin
| Study group | Role | What they receive |
|---|---|---|
| Egg white - Whey protein - Maltodextrin | Other | Participants will receive egg white, whey protein, and maltodextrin in this order. Receives: Dietary Supplement: Egg white; Dietary Supplement: Whey protein; Dietary Supplement: Maltodextrin |
| Egg white - Maltodextrin - Whey protein | Other | Participants will receive egg white, maltodextrin, and whey protein in this order. Receives: Dietary Supplement: Egg white; Dietary Supplement: Whey protein; Dietary Supplement: Maltodextrin |
| Whey protein - Egg white - Maltodextrin | Other | Participants will receive whey protein, egg white, and maltodextrin in this order. Receives: Dietary Supplement: Egg white; Dietary Supplement: Whey protein; Dietary Supplement: Maltodextrin |
| Whey protein - Maltodextrin - Egg white | Other | Participants will receive whey protein, maltodextrin, and egg white in this order. Receives: Dietary Supplement: Egg white; Dietary Supplement: Whey protein; Dietary Supplement: Maltodextrin |
| Maltodextrin - Egg white - Whey protein | Other | Participants will receive maltodextrin, egg white, and whey protein in this order. Receives: Dietary Supplement: Egg white; Dietary Supplement: Whey protein; Dietary Supplement: Maltodextrin |
| Maltodextrin - Whey protein - Egg white | Other | Participants will receive maltodextrin, whey protein, and egg white in this order. Receives: Dietary Supplement: Egg white; Dietary Supplement: Whey protein; Dietary Supplement: Maltodextrin |
What is being measured
The primary outcome is the main question the study is designed to answer.
Lean and fat mass pre-supplementation
Lean and fat mass of the whole body and its parts (trunk, legs and arms) will be assessed by dual X-ray absorptiometry.
Measured: Within 2 weeks before the beginning of supplementation.
Lean and fat mass post-supplementation
Lean and fat mass of the whole body and its parts (trunk, legs and arms) will be assessed by dual X-ray absorptiometry.
Measured: Within 2 weeks after the end of supplementation.
Maximal dynamic strength of shoulder muscles pre-supplementation
Maximal dynamic strength of shoulder muscles will be assessed by measurement of one-repetition maximum.
Measured: Within 2 weeks before the beginning of supplementation.
Maximal dynamic strength of shoulder muscles post-supplementation
Maximal dynamic strength of shoulder muscles will be assessed by measurement of one-repetition maximum.
Measured: Within 2 weeks after the end of supplementation.
Force-velocity relationship of knee flexors and extensors pre-supplementation
Force-velocity relationship of knee flexors and extensors will be assessed in isokinetic dynamometer.
Measured: Within 2 weeks before the beginning of supplementation.
Force-velocity relationship of knee flexors and extensors post-supplementation
Force-velocity relationship of knee flexors and extensors will be assessed in isokinetic dynamometer.
Measured: Within 2 weeks after the end of supplementation.
Plasma amino acid profile pre-supplementation
Plasma amino acid profile (that is, the concentration of each individual amino acid) will be determined by liquid chromatography - mass spectrometry.
Measured: Within 4 days before the beginning of supplementation.
Plasma amino acid profile post-supplementation
Plasma amino acid profile (that is, the concentration of each individual amino acid) will be determined by liquid chromatography - mass spectrometry.
Measured: Within 4 days after the end of supplementation.
Aerobic fitness pre-supplementation
Aerobic fitness will be assessed by measurement of maximal oxygen uptake through a maximal graded exercise test on treadmill.
Measured: Within 2 weeks before the beginning of supplementation.
Aerobic fitness post-supplementation
Aerobic fitness will be assessed by measurement of maximal oxygen uptake through a maximal graded exercise test on treadmill.
Measured: Within 2 weeks after the end of supplementation.
Muscle endurance pre-supplementation
Muscle endurance will be assessed by performing multiple sit-ups, knee flexions and knee extensions.
Measured: Within 2 weeks before the beginning of supplementation.
Muscle endurance post-supplementation
Muscle endurance will be assessed by performing multiple sit-ups, knee flexions and knee extensions.
Measured: Within 2 weeks after the end of supplementation.
Secondary outcomes (16)
Biochemical analyses pre-supplementation
Plasma glucose, triacylglycerols, total cholesterol, HDL cholesterol, LDL cholesterol, urea, and creatinine (all in mg/dL) will be measured by chemiluminescence in an automated analyzer.
Measured: Within 4 days before the beginning of supplementation.
Biochemical analyses post-supplementation
Plasma glucose, triacylglycerols, total cholesterol, HDL cholesterol, LDL cholesterol, urea, and creatinine (all in mg/dL) will be measured by chemiluminescence in an automated analyzer.
Measured: Within 4 days after the end of supplementation.
Hormonal analyses pre-supplementation
Plasma cortisol and testosterone (both in μg/dL) will be measured by immunoluminescence in an automated analyzer.
Measured: Within 4 days before the end of supplementation.
Hormonal analyses post-supplementation
Plasma cortisol and testosterone (both in μg/dL) will be measured by immunoluminescence in an automated analyzer.
Measured: Within 4 days after the end of supplementation.
Resting metabolic rate pre-supplementation
Resting metabolic rate will be assessed with indirect calorimetry through the measurement of oxygen consumption with a metabolic analyzer.
Measured: Within 2 weeks before the beginning of supplementation.
Resting metabolic rate post-supplementation
Resting metabolic rate will be assessed with indirect calorimetry through the measurement of oxygen consumption with a metabolic analyzer.
Measured: Within 2 weeks after the end of supplementation.
Internal load of exercise pre-supplementation
Internal load of exercise will be assessed by telemetric heart rate sensors and software
Measured: Within the first week of supplementation.
Internal load of exercise post-supplementation
Internal load of exercise will be assessed by telemetric heart rate sensors and software
Measured: Within the last week of supplementation (week 6).
Full blood count pre-supplementation
Full blood count will be performed by flow cytometry
Measured: Within 4 days before the beginning of supplementation
Full blood count post-supplementation
Full blood count will be performed by flow cytometry
Measured: Within 4 days after the end of supplementation.
Plasma enzymes pre-supplementation
Creatine kinase and γ-glutamyltransferase (both in U/L) will be measured by chemiluminescence in an automated analyzer
Measured: Within 4 days before the beginning of supplementation.
Plasma enzymes post-supplementation
Creatine kinase and γ-glutamyltransferase (both in U/L) will be measured by chemiluminescence in an automated analyzer.
Measured: Within 4 days after the end of supplementation.
Force-velocity relationship of shoulder muscles pre-supplementation
Force-velocity relationship of shoulder muscles will be assessed by a linear encoder.
Measured: Within 2 weeks before the beginning of supplementation.
Force-velocity relationship of shoulder muscles post-supplementation
Force-velocity relationship of shoulder muscles will be assessed by a linear encoder.
Measured: Within 2 weeks after the end of supplementation.
Maximal grip strength pre-supplementation
Maximal grip strength will be assessed by a hand dynamometer
Measured: Within 2 weeks before the beginning of supplementation
Maximal grip strength post-supplementation
Maximal grip strength will be assessed by a hand dynamometer
Measured: Within 2 weeks after the end of supplementation.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 May 2022
- Study start1 Nov 2021
- Primary completion31 Mar 2023
- Study completion30 Sep 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Exercise TrainingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Triple blind
- Who is masked
- Care provider, Investigator, Outcomes assessor
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- Aristotle University Of Thessaloniki
- Sponsor type
- University, hospital or other
- Collaborators
- European Commission, Greek Ministry of Development
- Responsible party
- Sponsor
- Investigators
- Vassilis Mougios, Principal investigator, Aristotle University Of Thessaloniki
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05396963
- Sponsor's protocol ID
- EGGPROScience1
- Status last verified
- Oct 2023
- First submitted
- 26 Apr 2022
- Last updated
- 5 Oct 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Oct 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Egg White Supplementation on Body Composition, Physical Performance, and Amino Acid Profile of Individuals Undergoing High-intensity Functional Training
- ClinicalTrials.gov ID
- NCT05396963
- Acronym / sponsor ID
- EGGPROScience1
- Conditions
- Exercise Training, Dietary Supplements
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- Aristotle University Of ThessalonikiUniversity, hospital or other
- Collaborators
- European Commission, Greek Ministry of Development
- Study start
- 1 Nov 2021 (actual)
- Primary completion
- 31 Mar 2023 (actual)
- Study completion
- 30 Sep 2023 (actual)
- First posted
- 31 May 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
High-intensity functional training (HIFT), a new version of high-intensity interval training, has gained interest in recent years. HIFT is based on the CrossFit training template and includes multijoint movement patterns via both endurance and strengthening exercises. Research has shown positive effects of HIFT on body composition, cardiorespiratory fitness, and muscle performance of young individuals. The effectiveness of HIFT in higher ages and its protein requirements are less well documented. Protein requirements have been widely investigated in resistance training, where it has been found that protein supplementation may have additive beneficial effects on muscle strength and lean body mass. However, there is a research gap regarding the adaptations to HIFT when combined with protein supplementation.
Thus, the aim of this research is to compare the effects of egg white supplementation, whey protein supplementation (as a positive comparator), and maltodextrin (a carbohydrate as placebo) on body composition, physical performance, and plasma amino acid profile in young and middle-aged trained individuals of both sexes who perform HIFT. Participants will take all three supplements for 6 weeks each, with 2 weeks of washout (no supplementation) in between, in random and counterbalanced order. Researchers will not know the supplementation status of the participants. Participants will receive 0.6 g of protein or placebo per kg body weight daily on top of isoenergetic dietary plans to avoid differences in energy intake that might compromise the validity of the study. The dietary plans will be individualized and will provided 1.0 g protein/kg body weight/day. The HIFT protocol will include multimodal patterns of movement, combining endurance and strengthening exercises with the use of equipment such as Total Resistance eXercise (TRX), Bosu, kettlebells, and barbells.
Participants will undergo measurements of muscle strength, muscle endurance, aerobic capacity, and body composition at the beginning and end of the study, as well as during the two washout periods. Also, plasma amino acids, hematology, biochemistry, and hormones will be measured. Comparison of all these outcome measures between supplements will reveal whether protein supplementation is useful in HIFT.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Triple blind (care provider, investigator, outcomes assessor)
- Number of arms
- 6
| Arm | Type | Receives |
|---|---|---|
| Egg white - Whey protein - Maltodextrin | Other | Dietary Supplement: Egg white, Dietary Supplement: Whey protein, Dietary Supplement: MaltodextrinParticipants will receive egg white, whey protein, and maltodextrin in this order. |
| Egg white - Maltodextrin - Whey protein | Other | Dietary Supplement: Egg white, Dietary Supplement: Whey protein, Dietary Supplement: MaltodextrinParticipants will receive egg white, maltodextrin, and whey protein in this order. |
| Whey protein - Egg white - Maltodextrin | Other | Dietary Supplement: Egg white, Dietary Supplement: Whey protein, Dietary Supplement: MaltodextrinParticipants will receive whey protein, egg white, and maltodextrin in this order. |
| Whey protein - Maltodextrin - Egg white | Other | Dietary Supplement: Egg white, Dietary Supplement: Whey protein, Dietary Supplement: MaltodextrinParticipants will receive whey protein, maltodextrin, and egg white in this order. |
| Maltodextrin - Egg white - Whey protein | Other | Dietary Supplement: Egg white, Dietary Supplement: Whey protein, Dietary Supplement: MaltodextrinParticipants will receive maltodextrin, egg white, and whey protein in this order. |
| Maltodextrin - Whey protein - Egg white | Other | Dietary Supplement: Egg white, Dietary Supplement: Whey protein, Dietary Supplement: MaltodextrinParticipants will receive maltodextrin, whey protein, and egg white in this order. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Regular training (mixed endurance and resistance training 3 to 6 times a week, 50 min each session, for the past 4 months), as assessed by gym records or questionnaires
- Clearance from a pathologist or cardiologist to perform maximal exercise
- Mixed isoenergetic diet for the past 4 months
Key exclusion criteria (9 listed)
- Smoking (even one cigarette or nicotine-containing device over the past 6 months)
- Any injuries to the musculoskeletal system that could interfere with the execution of training
- Chronic disease
- Egg allergy
- Milk allergy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Egg whiteIntake of egg white | Dietary supplement | Egg white - Maltodextrin - Whey protein, Egg white - Whey protein - Maltodextrin, Maltodextrin - Egg white - Whey protein, Maltodextrin - Whey protein - Egg white, Whey protein - Egg white - Maltodextrin, Whey protein - Maltodextrin - Egg white |
| Whey proteinIntake of whey protein | Dietary supplement | Egg white - Maltodextrin - Whey protein, Egg white - Whey protein - Maltodextrin, Maltodextrin - Egg white - Whey protein, Maltodextrin - Whey protein - Egg white, Whey protein - Egg white - Maltodextrin, Whey protein - Maltodextrin - Egg white |
| MaltodextrinIntake of maltodextrin | Dietary supplement | Egg white - Maltodextrin - Whey protein, Egg white - Whey protein - Maltodextrin, Maltodextrin - Egg white - Whey protein, Maltodextrin - Whey protein - Egg white, Whey protein - Egg white - Maltodextrin, Whey protein - Maltodextrin - Egg white |
Primary outcome
Lean and fat mass pre-supplementation
Time frame: Within 2 weeks before the beginning of supplementation.
Lean and fat mass of the whole body and its parts (trunk, legs and arms) will be assessed by dual X-ray absorptiometry.
Lean and fat mass post-supplementation
Time frame: Within 2 weeks after the end of supplementation.
Lean and fat mass of the whole body and its parts (trunk, legs and arms) will be assessed by dual X-ray absorptiometry.
Maximal dynamic strength of shoulder muscles pre-supplementation
Time frame: Within 2 weeks before the beginning of supplementation.
Maximal dynamic strength of shoulder muscles will be assessed by measurement of one-repetition maximum.
Maximal dynamic strength of shoulder muscles post-supplementation
Time frame: Within 2 weeks after the end of supplementation.
Maximal dynamic strength of shoulder muscles will be assessed by measurement of one-repetition maximum.
Force-velocity relationship of knee flexors and extensors pre-supplementation
Time frame: Within 2 weeks before the beginning of supplementation.
Force-velocity relationship of knee flexors and extensors will be assessed in isokinetic dynamometer.
Force-velocity relationship of knee flexors and extensors post-supplementation
Time frame: Within 2 weeks after the end of supplementation.
Force-velocity relationship of knee flexors and extensors will be assessed in isokinetic dynamometer.
Plasma amino acid profile pre-supplementation
Time frame: Within 4 days before the beginning of supplementation.
Plasma amino acid profile (that is, the concentration of each individual amino acid) will be determined by liquid chromatography - mass spectrometry.
Plasma amino acid profile post-supplementation
Time frame: Within 4 days after the end of supplementation.
Plasma amino acid profile (that is, the concentration of each individual amino acid) will be determined by liquid chromatography - mass spectrometry.
Aerobic fitness pre-supplementation
Time frame: Within 2 weeks before the beginning of supplementation.
Aerobic fitness will be assessed by measurement of maximal oxygen uptake through a maximal graded exercise test on treadmill.
Aerobic fitness post-supplementation
Time frame: Within 2 weeks after the end of supplementation.
Aerobic fitness will be assessed by measurement of maximal oxygen uptake through a maximal graded exercise test on treadmill.
Muscle endurance pre-supplementation
Time frame: Within 2 weeks before the beginning of supplementation.
Muscle endurance will be assessed by performing multiple sit-ups, knee flexions and knee extensions.
Muscle endurance post-supplementation
Time frame: Within 2 weeks after the end of supplementation.
Muscle endurance will be assessed by performing multiple sit-ups, knee flexions and knee extensions.
16 secondary outcomes
Biochemical analyses pre-supplementation
Time frame: Within 4 days before the beginning of supplementation.
Biochemical analyses post-supplementation
Time frame: Within 4 days after the end of supplementation.
Hormonal analyses pre-supplementation
Time frame: Within 4 days before the end of supplementation.
Hormonal analyses post-supplementation
Time frame: Within 4 days after the end of supplementation.
Resting metabolic rate pre-supplementation
Time frame: Within 2 weeks before the beginning of supplementation.
Resting metabolic rate post-supplementation
Time frame: Within 2 weeks after the end of supplementation.
Internal load of exercise pre-supplementation
Time frame: Within the first week of supplementation.
Internal load of exercise post-supplementation
Time frame: Within the last week of supplementation (week 6).
Full blood count pre-supplementation
Time frame: Within 4 days before the beginning of supplementation
Full blood count post-supplementation
Time frame: Within 4 days after the end of supplementation.
Plasma enzymes pre-supplementation
Time frame: Within 4 days before the beginning of supplementation.
Plasma enzymes post-supplementation
Time frame: Within 4 days after the end of supplementation.
Force-velocity relationship of shoulder muscles pre-supplementation
Time frame: Within 2 weeks before the beginning of supplementation.
Force-velocity relationship of shoulder muscles post-supplementation
Time frame: Within 2 weeks after the end of supplementation.
Maximal grip strength pre-supplementation
Time frame: Within 2 weeks before the beginning of supplementation
Maximal grip strength post-supplementation
Time frame: Within 2 weeks after the end of supplementation.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Oct 2023.
- Individual participant dataSharing planned: No
Related trials for Exercise Training
RecruitingPhase 2
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
Chronic Kidney Disease
Not yet recruiting
Combined Versus Multicomponent Training in People With Chronic Kidney Disease Stages 3a and 3b
Chronic Kidney Disease Stage 3A, Chronic Kidney Disease Stage 3B
Not yet recruiting
Radiofrequency and Pelvic Floor-Core Exercise for Chronic Low Back Pain in Women With Pelvic Floor Dysfunction
Chronic Low Back Pain, Urinary Incontinence
Recruiting
Evaluating the Feasibility of Prehabilitation Delivery Models for Patients Preparing for Gynecologic Cancer Surgery
Prehabilitation, Preoperative Aerobic Training
Recruiting
The Effect of Different Exercise Training Programs on Muscle Oxygenation in Individuals With Knee Osteoarthritis
Osteoarthritis of Knee
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Vassilis Mougios principal investigator
Aristotle University Of Thessaloniki
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Egg white, Whey protein and Maltodextrin in people with Exercise Training and Dietary Supplements, run by Aristotle University Of Thessaloniki at 1 site in Greece.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Lean and fat mass pre-supplementation (time frame: Within 2 weeks before the beginning of supplementation.). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2023.